The company fundamental is very good. The vaccine should be a good catalyst for the mid-term. The volume is still very low, but I'm happy holding it big though.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
